AzTrials
AzTrials

GingivitisNCT03624647

A Clinical Comparison of an Experimental Power Brush Compared to a Manual Toothbrush

A study testing Power toothbrush and Manual toothbrush in people with Gingivitis and Dental Plaque, run by Procter and Gamble at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of the study is to evaluate and compare the efficacy of an experimental power brush to a regular manual brush in the reduction of gingivitis and dental plaque over an 8 week period by using the Modified Gingival Index, the Gingival Bleeding Index and the Rustogi Modification of the Navy Plaque Index. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Gingivitis, Dental Plaque
What is being tested?
Power toothbrush and Manual toothbrush
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
110 participants
Where
1 siteCanada
Study dates
9 Jul 2018to 14 Sep 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • give written informed consent prior to study participation and be given a signed copy of their informed consent form
  • be at least 18 years of age and typically use a manual toothbrush;
  • be in good general health as determined by the investigator/designee based on a review/update of their medical history;
  • possess a minimum of 16 natural teeth with facial and lingual scorable surfaces;
  • have a Baseline pre-brushing MGI score of at least 1.75;
  • have a Baseline pre-brushing RMNPI score of greater than 0.5;
Show all 13Show fewer
  • have at least 20 bleeding sites (sites with a score of 1 or 2 on the GBI index) for Baseline pre-brushing;
  • agree not to participate in any other oral care study for the duration of this study;
  • agree to not to have any elective dentistry, including dental prophylaxis, until study completion and to report any non-study dentistry received at any time during the course of this study;
  • agree to refrain from using any non-study oral hygiene products for the study duration;
  • agree to return for all their scheduled visits and to follow all study procedures;
  • refrained from brushing their teeth or from performing any other oral hygiene procedures anytime within the 12 hours prior to their morning brushing and agree to follow these same restrictions prior to all visits except (the Week 1 p.m. visit);
  • refrained from any oral hygiene, eating, drinking* (except small sips of water), chewing gum, and tobacco use for at least 3 hours but not more than 6 hours prior to this visit and agree to follow these same restrictions prior to all p.m. visits.

Who cannot join

  • a condition requiring the need for antibiotic premedication prior to dental procedures;
  • severe periodontal disease, including but not limited to, purulent exudates, generalized mobility, and/or severe recession;
  • teeth that are grossly carious, fully crowned, or extensively restored;
  • active treatment for the following conditions: periodontitis, cancer, or a seizure disorder;
  • report to be nursing or pregnant, or intend to become pregnant any time during the course of this study;
  • taking an antibiotic or using a chlorhexidine mouth rinse any time within the previous 2 weeks;
Show all 9Show fewer
  • have any of the following: orthodontic appliances, removable partial dentures, peri/oral piercings, a pacemaker or other implanted device;
  • oral/gum surgery within the previous two months;
  • a disease or condition that could possibly interfere with examination/procedures or with the subject's safe completion of this study.

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • All Sum Research Ltd.

    Mississauga, Ontario, L4W0C2

Other trials in Canada

About this study

Official title: An 8-Week Clinical Comparison of an Experimental Power Brush Compared to a Manual Toothbrush in the Reduction of Gingivitis and Plaque

The objective of the study is to evaluate and compare the efficacy of an experimental power brush to a regular manual brush in the reduction of gingivitis and dental plaque over an 8 week period by using the Modified Gingival Index, the Gingival Bleeding Index and the Rustogi Modification of the Navy Plaque Index.

Being tested
Power toothbrush, Manual toothbrush
Medical subject headings
Gingivitis, Dental Plaque

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Power toothbrushDevice

    Experimental power toothbrush

  • Manual toothbrushDevice

    Marketed manual toothbrush

Study groups in NCT03624647
Study groupRoleWhat they receive
Power toothbrushExperimentalNot described
Receives: Device: Power toothbrush
Manual toothbrushPlacebo comparatorNot described
Receives: Device: Manual toothbrush

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Modified Gingival Index

    MGI is a validated assessment of Gingival inflammation using a 4 point range where 0 (absence of inflammation) to 4 (severe inflammation).

    Measured: Baseline

  2. Modified Gingival Index

    MGI is a validated assessment of Gingival inflammation using a 4 point range where 0 (absence of inflammation) to 4 (severe inflammation).

    Measured: Week 1

  3. Modified Gingival Index

    MGI is a validated assessment of Gingival inflammation using a 4 point range where 0 (absence of inflammation) to 4 (severe inflammation).

    Measured: Week 8

  4. Rustogi Modification of the Navy Plaque Index

    RMNPI is a validated assessment of visual surface dental plaque using a dichotomous scale 0 (absence) to 1 (presence).

    Measured: Baseline

  5. Rustogi Modification of the Navy Plaque Index

    RMNPI is a validated assessment of visual surface dental plaque using a dichotomous scale 0 (absence) to 1 (presence).

    Measured: Week 1

  6. Rustogi Modification of the Navy Plaque Index

    RMNPI is a validated assessment of visual surface dental plaque using a dichotomous scale 0 (absence) to 1 (presence).

    Measured: Week 8

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Aug 2018
  2. Study start9 Jul 2018
  3. Primary completion14 Sep 2018
  4. Study completion14 Sep 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
110 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03624647
Sponsor's protocol ID
2018030
Status last verified
Sep 2018
First submitted
6 Aug 2018
Last updated
27 Sep 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Power toothbrush and Manual toothbrush in people with Gingivitis and Dental Plaque, run by Procter and Gamble at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Modified Gingival Index (time frame: Baseline). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Sep 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in